{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:39:58Z","timestamp":1774265998369,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.cccn.2004.04.027","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T15:08:50Z","timestamp":1096988930000},"page":"1-13","source":"Crossref","is-referenced-by-count":15,"title":["Advances in the clinical laboratory detection of gestational trophoblastic disease"],"prefix":"10.1016","volume":"349","author":[{"given":"Katsuyoshi","family":"Seki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souei","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cccn.2004.04.027_BIB1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1471-7697(03)00047-9","article-title":"Gestational trophoblastic disease","volume":"3","author":"Ngan","year":"2003","journal-title":"Rev. Gynaecol. Pract"},{"key":"10.1016\/j.cccn.2004.04.027_BIB2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1521-6934(03)00098-1","article-title":"Diagnosis and management of gestational trophoblastic neoplasia","volume":"17","author":"Ng","year":"2003","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00003081-200309000-00008","article-title":"Staging and evaluation of gestational trophoblastic disease","volume":"46","author":"Soper","year":"2003","journal-title":"Clin. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00003081-200309000-00004","article-title":"Pathology of gestational trophoblastic disease","volume":"46","author":"Bentley","year":"2003","journal-title":"Clin. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1054\/cuog.2002.0316","article-title":"Gestational trophoblastic disease","volume":"13","author":"Ngan","year":"2003","journal-title":"Curr. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000","volume":"77","author":"FIGO Oncology Committee (Ngan HYS)","year":"2002","journal-title":"Int. J. Gynecol. Obstet"},{"key":"10.1016\/j.cccn.2004.04.027_BIB7","series-title":"Gestational Trophoblastic Disease","article-title":"The FiGO 2000 staging and risk factor scoring system for gestational trophoblastic neoplasia","author":"Kohorn","year":"2000"},{"key":"10.1016\/j.cccn.2004.04.027_BIB8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2002.6622","article-title":"Persistent low-level \u201creal\u201d human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma","volume":"85","author":"Kohon","year":"2002","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinchem\/47.2.308","article-title":"Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic disease","volume":"47","author":"Cole","year":"2001","journal-title":"Clin. Chem"},{"key":"10.1016\/j.cccn.2004.04.027_BIB10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00003081-200309000-00005","article-title":"HCG tests in the management of gestational trophoblastic diseases","volume":"46","author":"Cole","year":"2003","journal-title":"Clin. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0002-9378(72)90553-4","article-title":"A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone","volume":"113","author":"Vaitukaitis","year":"1972","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB12","first-page":"193","article-title":"Detecting and monitoring trophoblastic disease: new perspectives on measuring human chorionic gonadotropin levels","volume":"39","author":"Cole","year":"1994","journal-title":"J. Reprod. Med"},{"key":"10.1016\/j.cccn.2004.04.027_BIB13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/endo-123-1-572","article-title":"Structure of the human chorionic gonadotropin \u03b2-subunit fragment from pregnancy urine","volume":"123","author":"Birken","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.cccn.2004.04.027_BIB14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1525-1438.2000.010004330.x","article-title":"Nicked human chorionic gonadotropin in trophoblastic disease","volume":"10","author":"Kohorn","year":"2000","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.cccn.2004.04.027_BIB15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinchem\/38.2.263","article-title":"Discordant results in human chorionic gonadotropin assays","volume":"38","author":"Cole","year":"1992","journal-title":"Clin. Chem"},{"key":"10.1016\/j.cccn.2004.04.027_BIB16","first-page":"433","article-title":"Detection of hCG in trophoblastic disease: the USA reference service experience","volume":"47","author":"Cole","year":"2002","journal-title":"J. Reprod. Med"},{"key":"10.1016\/j.cccn.2004.04.027_BIB17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/gyno.1998.5181","article-title":"Phantom hCG and phantom choriocarcinoma","volume":"71","author":"Cole","year":"1998","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(00)01324-6","article-title":"False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations","volume":"355","author":"Rotmensch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cccn.2004.04.027_BIB19","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.248.19.2489","article-title":"Heterophilic antibodies interfering with radioimmunoassay: a false pregnancy test","volume":"248","author":"Vladutiu","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.cccn.2004.04.027_BIB20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/clinchem\/47.7.1332","article-title":"Use of heterophilic antibody blocking agent (HBT) in reducing false postive hCG results","volume":"47","author":"Butler","year":"2001","journal-title":"Clin. Chem"},{"key":"10.1016\/j.cccn.2004.04.027_BIB21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0029-7844(02)02619-4","article-title":"Heterophile antibody blocking agent to confirm false positive serum human chorionic gonadotropin assay","volume":"101","author":"Esfandiari","year":"2003","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/00016348909028676","article-title":"Heterophilic antibodies against rabbit serum causing falsely elevated gonadotropin levels","volume":"68","author":"Berglund","year":"1989","journal-title":"Acta Obstet. Gynecol. Scand"},{"key":"10.1016\/j.cccn.2004.04.027_BIB23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/clinchem\/38.9.1737","article-title":"Eliminating interference from heterophilic antibodies in a two-site immunoassay for creatinine kinase MB by using F(ab\u2032)2 conjugate and polyclonal mouse IgG","volume":"38","author":"Vaidya","year":"1992","journal-title":"Clin. Chem"},{"key":"10.1016\/j.cccn.2004.04.027_BIB24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0029-7844(01)01774-4","article-title":"Falsely elevated human chorionic gonadotropin leading to unnecessary therapy","volume":"99","author":"Butler","year":"2002","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ajcp\/108.4.417","article-title":"Heterophilic antibodies remain a problem for the immunoassay laboratory","volume":"108","author":"Ward","year":"1997","journal-title":"Am. J. Clin. Pathol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1034\/j.1600-0412.2003.00154.x","article-title":"Early and late half-life of human chorionic gonadotropin as a predictor of persistent trophoblast after laparoscopic conservative surgery for tubal pregnancy","volume":"82","author":"Billieux","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand"},{"key":"10.1016\/j.cccn.2004.04.027_BIB27","series-title":"Laboratory Updates","article-title":"False elevation of serum hCG","author":"Chu","year":"2003"},{"key":"10.1016\/j.cccn.2004.04.027_BIB28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1034\/j.1600-0412.2003.00017.x","article-title":"Serum-hCG: still a problematic marker","volume":"82","author":"Rode","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand"},{"issue":"Suppl. S6","key":"10.1016\/j.cccn.2004.04.027_BIB29","first-page":"A92","article-title":"Falsely elevated HCG results with AXSYM assay","volume":"49","author":"Pesce","year":"2003","journal-title":"Clin. Chem"},{"key":"10.1016\/j.cccn.2004.04.027_BIB30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mob.2003.271","article-title":"Persistent low levels of human chorionic gonadotropin: a premalignant gestational trophoblastic disease","volume":"188","author":"Khanlian","year":"2003","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB31","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/clinchem\/45.12.2109","article-title":"Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational down syndrome screening","volume":"45","author":"Cole","year":"1999","journal-title":"Clin. Chem"},{"key":"10.1016\/j.cccn.2004.04.027_BIB32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(02)00135-1","article-title":"Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source of choriocarcinoma-like hCG","volume":"194","author":"Kovalevskaya","year":"2002","journal-title":"Mol. Cell. Endcrinol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB33","article-title":"Problems of interpretation of persistent low levels of hCG in patients suspected of having gestational trophoblastic disease (GTD)","author":"Newlands","year":"2001"},{"key":"10.1016\/j.cccn.2004.04.027_BIB34","article-title":"Quiescent gestational trophoblastic disease (GTD): how common is it and what is its outcome?","author":"Hancock","year":"2001"},{"key":"10.1016\/j.cccn.2004.04.027_BIB35","article-title":"Persistent low levels of hCG","author":"Cole","year":"2003"},{"key":"10.1016\/j.cccn.2004.04.027_BIB36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1210\/jcem-49-6-917","article-title":"Widespread distribution of a chorionic gonadotropin-like substance in normal human tissues","volume":"49","author":"Braunstein","year":"1979","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB37","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM198712313172702","article-title":"Pulsatile secretion of human chorionic gonadotropin in normal adults","volume":"317","author":"Odell","year":"1987","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.cccn.2004.04.027_BIB38","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1210\/jcem-69-3-528","article-title":"Pulsatile secretion of chorionic gonadotropin during the normal menstrual cycle","volume":"69","author":"Odell","year":"1989","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/jcem-72-4-747","article-title":"A chorionic gonadotropin-secreting human pituitary cell","volume":"72","author":"Hammond","year":"1991","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB40","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1210\/en.137.4.1402","article-title":"Isolation and characterization of human pituitary chorionic gonadotropin","volume":"137","author":"Birken","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.cccn.2004.04.027_BIB41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1067\/mob.2002.124284","article-title":"False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition","volume":"187","author":"Braunstein","year":"2002","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1210\/jcem-64-4-730","article-title":"Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonadotropin-releasing hormone and sex steroids","volume":"64","author":"Stenman","year":"1987","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB43","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1210\/jc.78.6.1293","article-title":"Gonadotropin-releasing hormone-dependent chorionic gonadotropin secretion in a menopausal women","volume":"78","author":"Daiter","year":"1994","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB44","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0002-9378(98)70345-X","article-title":"Human chorionic gonadotropin production by the pituitary gland in a premenopausal women","volume":"178","author":"Patton","year":"1998","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB45","first-page":"3","article-title":"HCG, its free subunits and its metabolites","volume":"43","author":"Cole","year":"1998","journal-title":"J. Reprod. Med"},{"key":"10.1016\/j.cccn.2004.04.027_BIB46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/jcem-64-2-313","article-title":"Radioimmunoassay of the serum free \u03b2-subunit of human chorionic gonadotropin in trophoblastic disease","volume":"64","author":"Fan","year":"1987","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0002-9378(88)90809-5","article-title":"Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease","volume":"158","author":"Ozturk","year":"1988","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB48","first-page":"212","article-title":"Human chorionic gonadotropin and free subunits' serum level in patients with partial and complete hydatidiform moles","volume":"74","author":"Berkowitz","year":"1989","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0010-7824(98)00028-6","article-title":"Identification of choriocarcinoma by the hCG\u03b2-to-hCG proportion in patients with delayed diagnosis caused by contraceptive use","volume":"57","author":"Vartiainen","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.cccn.2004.04.027_BIB50","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0002-9378(86)90818-5","article-title":"Radioimmunoassay of free \u03b2-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy","volume":"155","author":"Khazaeli","year":"1986","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB51","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/gyno.1999.5438","article-title":"Following metastatic placental site tumor with urine \u03b2-core fragment","volume":"74","author":"Rinne","year":"1999","journal-title":"Gynecol. Oncol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1373\/49.5.808","article-title":"Fully automated chemiluminometric assay for hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen)","volume":"49","author":"Pandian","year":"2003","journal-title":"Clin. Chem"},{"key":"10.1016\/j.cccn.2004.04.027_BIB53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.173.3991.56","article-title":"Primary structure of the human chorionic somatomammotropin (HCS) molecule","volume":"173","author":"Li","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.cccn.2004.04.027_BIB54","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1073\/pnas.68.4.866","article-title":"Sequences of pituitary and placental lactogenic growth hormones: evolution from a primordial peptide by gene reduplication","volume":"68","author":"Niall","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cccn.2004.04.027_BIB55","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/jcem-26-12-1303","article-title":"Serum placental lactogen during pregnancy and in trophoblastic disease","volume":"26","author":"Samaan","year":"1966","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9378(68)90441-9","article-title":"Serum placental lactogen levels in patients with molar pregnancy and trophoblastic tumors","volume":"102","author":"Saxena","year":"1968","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB57","first-page":"86","article-title":"Radioimmunoassay of serum chorionic gonadotropin and placental lactogen in trophoblastic disease","volume":"32","author":"Yen","year":"1968","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0002-9378(71)90703-4","article-title":"Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors\u2014a reliable index of malignancy","volume":"110","author":"Goldstein","year":"1971","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00003081-200309000-00011","article-title":"The clinical behavior of placental site trophoblastic tumor and contemporary methods of management","volume":"46","author":"Danity","year":"2003","journal-title":"Clin. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB60","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0046-8177(98)90048-X","article-title":"Placental site trophoblastic tumor: human placental lactogen and pregnancy-associated major basic protein as immunohistologic markers","volume":"29","author":"Rhoton-Vlasak","year":"1998","journal-title":"Hum. Pathol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0006-291X(85)90594-7","article-title":"Isolation of inhibin from bovine follicular fluid","volume":"126","author":"Robertson","year":"1985","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.cccn.2004.04.027_BIB62","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/321776a0","article-title":"Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid","volume":"321","author":"Vale","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.cccn.2004.04.027_BIB63","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/er.22.6.836","article-title":"Activins and inhibins in endocrine and other tumors","volume":"22","author":"Risbridger","year":"2001","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.cccn.2004.04.027_BIB64","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1210\/jc.85.12.4851","article-title":"Localization of activin \u03b2A-, \u03b2B-, and \u03b2C-subunits in human prostate and evidence for formation of new activin heterodimers of \u03b2C-subunit","volume":"85","author":"Mellor","year":"2000","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1006\/bbrc.1995.1699","article-title":"Molecular cloning and functional analysis of a new activin \u03b2 subunit: a dorsal mesoderm-inducing activity in Xenopus","volume":"210","author":"Oda","year":"1995","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.cccn.2004.04.027_BIB66","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1471-0528.1996.tb09541.x","article-title":"Inhibins and activins: roles in clinical practice","volume":"103","author":"Wallace","year":"1996","journal-title":"Br. J. Obstet. Gynaecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/edrv-9-2-267","article-title":"Inhibins, activins, follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone","volume":"9","author":"Ying","year":"1988","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.cccn.2004.04.027_BIB68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1006\/frne.1996.0013","article-title":"Roles of inhibins, activins and follistatin in the female reproductive system","volume":"17","author":"Knight","year":"1996","journal-title":"Front. Neuroendocrinol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/edrv-16-4-485","article-title":"Inhibin and activin production in human placenta","volume":"16","author":"Qu","year":"1995","journal-title":"Endocr. Rev"},{"key":"10.1016\/j.cccn.2004.04.027_BIB70","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1046\/j.1365-2559.1998.00385.x","article-title":"Localization of the cellular expression of inhibin in trophoblastic tissue","volume":"32","author":"McCluggage","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.cccn.2004.04.027_BIB71","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004347-199904000-00008","article-title":"Immunohistochemical localization of inhibin-\u03b1 in the placenta and gestational trophoblastic lesions","volume":"18","author":"Shih","year":"1999","journal-title":"Int. J. Gynecol. Pathol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0046-8177(99)90296-4","article-title":"Detection of the alpha-subunit of inhibin in trophoblastic neoplasia","volume":"30","author":"Pelky","year":"1999","journal-title":"Human Pathol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB73","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00000478-199811000-00010","article-title":"Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma","volume":"22","author":"Shih","year":"1998","journal-title":"Am. J. Surg. Pathol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB74","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1136\/bmj.298.6689.1684","article-title":"Inhibin: a new circulating marker of hydatidiform mole?","volume":"298","author":"Yohkaichiya","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.cccn.2004.04.027_BIB75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2265.1994.tb02524.x","article-title":"Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free \u03b2-subunit","volume":"41","author":"Badonnel","year":"1994","journal-title":"Clin. Endocrinol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB76","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2265.1994.tb02504.x","article-title":"Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay","volume":"40","author":"Groome","year":"1994","journal-title":"Clin. Endocrinol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB77","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1210\/jc.80.10.2926","article-title":"Quantification of inhibin pro-\u03b1C-containing forms in human serum by a new ultrasensitive two-site enzyme linked immunosorbent assay","volume":"80","author":"Groome","year":"1995","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB78","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/jc.81.4.1401","article-title":"Measurement of dimeric inhibin B throughout the human menstrual cycle","volume":"81","author":"Groome","year":"1996","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB79","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1210\/jc.81.9.3328","article-title":"Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy","volume":"81","author":"Muttukrishna","year":"1996","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB80","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1210\/jc.81.4.1471","article-title":"Measurement of circulating inhibin forms during the establishment of pregnancy","volume":"81","author":"Illingworth","year":"1996","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1016\/j.cccn.2004.04.027_BIB81","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/humrep\/13.12.3530","article-title":"A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-AB, pro-\u03b1C and follistatin during pregnancy","volume":"13","author":"Fowler","year":"1998","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.cccn.2004.04.027_BIB82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000067709","article-title":"Circulating inhibin forms in patients with hydatidiform mole","volume":"54","author":"Kato","year":"2002","journal-title":"Gynecol. Obstet. Invest"},{"key":"10.1016\/j.cccn.2004.04.027_BIB83","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/cncr.10524","article-title":"Serum activin A and inhibin B: new clinical markers for hydatidiform mole","volume":"94","author":"Florio","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cccn.2004.04.027_BIB84","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF03347296","article-title":"Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy","volume":"21","author":"Florio","year":"1988","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.cccn.2004.04.027_BIB85","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1093\/humrep\/16.11.2434","article-title":"Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?","volume":"16","author":"Pautier","year":"2001","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.cccn.2004.04.027_BIB86","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9378(74)90006-4","article-title":"Progesterone concentrations in the sera of patients with intact and aborted hydatidiform moles","volume":"119","author":"Dawood","year":"1974","journal-title":"Am. J. Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB87","first-page":"381","article-title":"Serum relaxin in patients with hydatidiform mole","volume":"67","author":"Seki","year":"1986","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB88","first-page":"99","article-title":"Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation","volume":"67","author":"Ho","year":"1986","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB89","first-page":"9","article-title":"Disappearance of serum progesterone after normal delivery and removal of hydatidiform mole","volume":"45","author":"Dawood","year":"1975","journal-title":"Obstet. Gynecol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB90","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1530\/acta.0.0790729","article-title":"The significance of serum progesterone and serum unconjugated oestradiol-17\u03b2 in unaborted hydatidiform mole","volume":"79","author":"Dawood","year":"1975","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.cccn.2004.04.027_BIB91","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/gyno.1994.1212","article-title":"Serum progesterone monitoring in post-molar surveillance","volume":"54","author":"Vasilev","year":"1994","journal-title":"Gynecol. Oncol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898104002293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898104002293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T08:22:14Z","timestamp":1585902134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898104002293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":91,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0009898104002293"],"URL":"https:\/\/doi.org\/10.1016\/j.cccn.2004.04.027","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}